↓ Skip to main content

Nuclear Signaling Pathways and Targeting Transcription in Cancer

Overview of attention for book
Cover of 'Nuclear Signaling Pathways and Targeting Transcription in Cancer'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Steroid Receptor Coactivators (SRCs) as Integrators of Multiple Signaling Pathways in Cancer Progression
  3. Altmetric Badge
    Chapter 2 Role of Alteration/Deficiency in Activation (ADA) Complex in Cell Cycle, Genomic Instability and Cancer
  4. Altmetric Badge
    Chapter 3 RUNX2 Transcriptional Regulation in Development and Disease
  5. Altmetric Badge
    Chapter 4 Epigenetic Mechanisms of Cancer Metastasis
  6. Altmetric Badge
    Chapter 5 Regulatory Effects of Arsenic on Cellular Signaling Pathways: Biological Effects and Therapeutic Implications
  7. Altmetric Badge
    Chapter 6 Nuclear Factors Linking Cancer and Inflammation
  8. Altmetric Badge
    Chapter 7 Regulation of the Jak/STATs Pathways by Histone Deacetylases
  9. Altmetric Badge
    Chapter 8 Receptor Tyrosine Kinases in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers
  10. Altmetric Badge
    Chapter 9 Nucleolar Signaling Determines Cell Fate: The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis
  11. Altmetric Badge
    Chapter 10 Transcriptional Regulation of Lipogenesis as a Therapeutic Target for Cancer Treatment
  12. Altmetric Badge
    Chapter 11 Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology
  13. Altmetric Badge
    Chapter 12 Domain Specific Targeting of Cancer
  14. Altmetric Badge
    Chapter 13 The Potential of Targeting Splicing for Cancer Therapy
  15. Altmetric Badge
    Chapter 14 Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old) Targets and Potential Strategies
  16. Altmetric Badge
    Chapter 15 Histone Demethylases in Prostate Cancer
  17. Altmetric Badge
    Chapter 16 Therapeutic Significance of Chromatin Remodeling Complexes in Cancer
Attention for Chapter 11: Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology
Chapter number 11
Book title
Nuclear Signaling Pathways and Targeting Transcription in Cancer
Published by
Humana Press, New York, NY, January 2014
DOI 10.1007/978-1-4614-8039-6_11
Book ISBNs
978-1-4614-8038-9, 978-1-4614-8039-6
Authors

Susanne Müller, Hannah Lingard, Stefan Knapp

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 29%
Student > Bachelor 2 29%
Professor > Associate Professor 1 14%
Researcher 1 14%
Unknown 1 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 29%
Medicine and Dentistry 2 29%
Chemistry 1 14%
Biochemistry, Genetics and Molecular Biology 1 14%
Unknown 1 14%